Table 1. VMAT2 Inhibitors Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. VMAT2 Inhibitors Market Restraints

Table 3. VMAT2 Inhibitors Market Trends

Table 4. VMAT2 Inhibitors Industry Policy

Table 5. Global VMAT2 Inhibitors Revenue by Company, 2019-2024, US$ million

Table 6. Global VMAT2 Inhibitors Revenue Market Share by Company, 2019-2024

Table 7. Global VMAT2 Inhibitors Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global VMAT2 Inhibitors Sales Volume Market Share by Company, 2019-2024

Table 9. Global VMAT2 Inhibitors Price by Company, 2019-2024, (US$/Unit)

Table 10. Global VMAT2 Inhibitors Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global VMAT2 Inhibitors Mergers & Acquisitions, Expansion Plans

Table 12. Global VMAT2 Inhibitors Manufacturers Product Type

Table 13. China VMAT2 Inhibitors Revenue by Company, 2019-2024, US$ million

Table 14. China VMAT2 Inhibitors Revenue Market Share by Company, 2019-2024

Table 15. China VMAT2 Inhibitors Sales Volume by Company, 2019-2024, (K Units)

Table 16. China VMAT2 Inhibitors Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, VMAT2 Inhibitors Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China VMAT2 Inhibitors Import & Export Trends

Table 19. Main Sources of China VMAT2 Inhibitors Import

Table 20. Export Destination of China VMAT2 Inhibitors

Table 21. Global Headquarters and Manufacturing Base of VMAT2 Inhibitors Manufacturers

Table 22. Global Major Manufacturers, VMAT2 Inhibitors Capacity Expansion and Future Plans

Table 23. Global VMAT2 Inhibitors Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global VMAT2 Inhibitors Production by Region, 2019-2024, (K Units)

Table 25. Global VMAT2 Inhibitors Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of VMAT2 Inhibitors Upstream (Raw Materials)

Table 27. Global VMAT2 Inhibitors Typical Customers

Table 28. VMAT2 Inhibitors Typical Distributors

Table 29. By Type, Global VMAT2 Inhibitors Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global VMAT2 Inhibitors Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global VMAT2 Inhibitors Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global VMAT2 Inhibitors Revenue, 2019-2030, US$ Million

Table 33. By Region, Global VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global VMAT2 Inhibitors Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global VMAT2 Inhibitors Revenue, 2019-2030, US$ Million

Table 36. By Country, Global VMAT2 Inhibitors Revenue Market Share, 2019-2030

Table 37. By Country, Global VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global VMAT2 Inhibitors Sales Volume Market Share, 2019-2030

Table 39. Neurocrine Biosciences, Inc Company Information, Head Office, Market Area and Industry Position

Table 40. Neurocrine Biosciences, Inc VMAT2 Inhibitors Models, Specifications and Application

Table 41. Neurocrine Biosciences, Inc VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Neurocrine Biosciences, Inc Company Profile and Main Business

Table 43. Neurocrine Biosciences, Inc Recent Developments

Table 44. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 45. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Models, Specifications and Application

Table 46. Teva Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Teva Pharmaceutical Industries Ltd Company Profile and Main Business

Table 48. Teva Pharmaceutical Industries Ltd Recent Developments

Table 49. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 50. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Models, Specifications and Application

Table 51. Sun Pharmaceutical Industries Ltd VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Sun Pharmaceutical Industries Ltd Company Profile and Main Business

Table 53. Sun Pharmaceutical Industries Ltd Recent Developments

Table 54. Hikma Pharmaceuticals plc Company Information, Head Office, Market Area and Industry Position

Table 55. Hikma Pharmaceuticals plc VMAT2 Inhibitors Models, Specifications and Application

Table 56. Hikma Pharmaceuticals plc VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Hikma Pharmaceuticals plc Company Profile and Main Business

Table 58. Hikma Pharmaceuticals plc Recent Developments

Table 59. Hetero Company Information, Head Office, Market Area and Industry Position

Table 60. Hetero VMAT2 Inhibitors Models, Specifications and Application

Table 61. Hetero VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Hetero Company Profile and Main Business

Table 63. Hetero Recent Developments

Table 64. Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position

Table 65. Bausch Health Companies Inc VMAT2 Inhibitors Models, Specifications and Application

Table 66. Bausch Health Companies Inc VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Bausch Health Companies Inc Company Profile and Main Business

Table 68. Bausch Health Companies Inc Recent Developments

Table 69. Dr. Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position

Table 70. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Models, Specifications and Application

Table 71. Dr. Reddy's Laboratories Ltd VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Dr. Reddy's Laboratories Ltd Company Profile and Main Business

Table 73. Dr. Reddy's Laboratories Ltd Recent Developments

Table 74. Piramal Pharma Solution Company Information, Head Office, Market Area and Industry Position

Table 75. Piramal Pharma Solution VMAT2 Inhibitors Models, Specifications and Application

Table 76. Piramal Pharma Solution VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Piramal Pharma Solution Company Profile and Main Business

Table 78. Piramal Pharma Solution Recent Developments

Table 79. Lupin Company Information, Head Office, Market Area and Industry Position

Table 80. Lupin VMAT2 Inhibitors Models, Specifications and Application

Table 81. Lupin VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Lupin Company Profile and Main Business

Table 83. Lupin Recent Developments

Table 84. Luye Pharma Group Company Information, Head Office, Market Area and Industry Position

Table 85. Luye Pharma Group VMAT2 Inhibitors Models, Specifications and Application

Table 86. Luye Pharma Group VMAT2 Inhibitors Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Luye Pharma Group Company Profile and Main Business

Table 88. Luye Pharma Group Recent Developments

List of Figure

Figure 1. VMAT2 Inhibitors Picture

Figure 2. By Revenue, Global VMAT2 Inhibitors Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global VMAT2 Inhibitors Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global VMAT2 Inhibitors Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China VMAT2 Inhibitors Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China VMAT2 Inhibitors Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China VMAT2 Inhibitors Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China VMAT2 Inhibitors Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China VMAT2 Inhibitors Share of Global Market, 2019-2030

Figure 10. Global VMAT2 Inhibitors Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global VMAT2 Inhibitors Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China VMAT2 Inhibitors Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China VMAT2 Inhibitors Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China VMAT2 Inhibitors Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of VMAT2 Inhibitors Domestic VS Export, 2022

Figure 16. Global VMAT2 Inhibitors Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global VMAT2 Inhibitors Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global VMAT2 Inhibitors Production Market Share & Forecast by Region, 2019-2030

Figure 19. VMAT2 Inhibitors Industry Chain

Figure 20. VMAT2 Inhibitors Procurement Model

Figure 21. VMAT2 Inhibitors Sales Model

Figure 22. VMAT2 Inhibitors Sales Channels, Direct Sales and Distribution

Figure 23. Tetrabenazine

Figure 24. Valbenazine

Figure 25. Other

Figure 26. By Type, Global VMAT2 Inhibitors Revenue, 2019-2030, US$ Million

Figure 27. By Type, Global VMAT2 Inhibitors Revenue Market Share, 2019-2030

Figure 28. By Type, Global VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 29. By Type, Global VMAT2 Inhibitors Sales Volume Market Share, 2019-2030

Figure 30. By Type, Global VMAT2 Inhibitors Price, 2019-2030, (US$/Unit)

Figure 31. Huntington’s Disease

Figure 32. Tardive Dyskinesia

Figure 33. Other

Figure 34. By Application, Global VMAT2 Inhibitors Revenue, 2019-2030, US$ Million

Figure 35. By Application, Global VMAT2 Inhibitors Revenue Market Share, 2019-2030

Figure 36. By Application, Global VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 37. By Application, Global VMAT2 Inhibitors Sales Volume Market Share, 2019-2030

Figure 38. By Application, Global VMAT2 Inhibitors Price, 2019-2030, (US$/Unit)

Figure 39. By Region, Global VMAT2 Inhibitors Revenue Market Share, 2019-2030

Figure 40. By Region, Global VMAT2 Inhibitors Sales Volume Market Share, 2019-2030

Figure 41. North America VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, North America VMAT2 Inhibitors Revenue Market Share, 2022

Figure 43. Europe VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, Europe VMAT2 Inhibitors Revenue Market Share, 2022

Figure 45. Asia Pacific VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country/Region, Asia Pacific VMAT2 Inhibitors Revenue Market Share, 2022

Figure 47. South America VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country, South America VMAT2 Inhibitors Revenue Market Share, 2022

Figure 49. Middle East & Africa VMAT2 Inhibitors Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. U.S. VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 51. By Company, U.S. VMAT2 Inhibitors Market Share, 2022

Figure 52. By Type, U.S. VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 55. By Company, Europe VMAT2 Inhibitors Market Share, 2022

Figure 56. By Type, Europe VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 58. China VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 59. By Company, China VMAT2 Inhibitors Market Share, 2022

Figure 60. By Type, China VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 63. By Company, Japan VMAT2 Inhibitors Market Share, 2022

Figure 64. By Type, Japan VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 67. By Company, South Korea VMAT2 Inhibitors Market Share, 2022

Figure 68. By Type, South Korea VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 71. By Company, Southeast Asia VMAT2 Inhibitors Market Share, 2022

Figure 72. By Type, Southeast Asia VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 74. India VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 75. By Company, India VMAT2 Inhibitors Market Share, 2022

Figure 76. By Type, India VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia VMAT2 Inhibitors Sales Volume, 2019-2030, (K Units)

Figure 79. By Company, Middle East & Asia VMAT2 Inhibitors Market Share, 2022

Figure 80. By Type, Middle East & Asia VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia VMAT2 Inhibitors Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches